Država: Novi Zeland
Jezik: engleski
Izvor: Medsafe (Medicines Safety Authority)
Rosuvastatin calcium 5.198mg equivalent to rosuvastatin 5 mg;
Viatris Limited
Rosuvastatin calcium 5.198 mg (equivalent to rosuvastatin 5 mg)
5 mg
Film coated tablet
Active: Rosuvastatin calcium 5.198mg equivalent to rosuvastatin 5 mg Excipient: Colloidal silicon dioxide Crospovidone Iron oxide red Lactose monohydrate Light magnesium oxide Magnesium stearate Microcrystalline cellulose Opadry Yellow
Blister pack, laminate layer (polyamide/aluminium/LDPE dessicant-HDPE)/aluminium foil, 30 tablets
Prescription
Prescription
Assia Chemical Industries Ltd
Rosuvastatin calcium is indicated to: · Reduce elevated LDL-C, total cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). Rosuvastatin calcium also lowers ApoB, nonHDL-C, VLDL-C, VLDL-TG, the LDL-C/HDL-C, total C/HDL-C, nonHDL-C/HDL-C, ApoB/ApoA-I ratios and increase Apo-A-I in these populations. · Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). · Reduce total cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or alone if such treatments are unavailable.
Package - Contents - Shelf Life: Blister pack, PVC/Aclar/Al, PVC/Polyamide/Al or polyamide/Al/LDPE dessicant-HDPE)/Al - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE white bottle/PP screw closure - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE white bottle/PP screw closure - 500 tablets - 24 months from date of manufacture stored at or below 25°C
2013-04-03